Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrointestinal Microbiome | 17 | 2023 | 172 | 1.850 |
Why?
|
Microbiota | 15 | 2024 | 100 | 1.730 |
Why?
|
Vaginosis, Bacterial | 6 | 2024 | 28 | 1.160 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2021 | 115 | 0.890 |
Why?
|
Staphylococcal Infections | 6 | 2021 | 151 | 0.890 |
Why?
|
Circadian Rhythm | 5 | 2022 | 231 | 0.650 |
Why?
|
Feces | 10 | 2023 | 105 | 0.600 |
Why?
|
Dysbiosis | 5 | 2018 | 55 | 0.520 |
Why?
|
Oligosaccharides | 3 | 2021 | 17 | 0.510 |
Why?
|
Inflammation | 4 | 2021 | 264 | 0.470 |
Why?
|
Colon | 6 | 2023 | 137 | 0.460 |
Why?
|
Parkinson Disease | 4 | 2023 | 826 | 0.370 |
Why?
|
Prebiotics | 3 | 2023 | 21 | 0.360 |
Why?
|
Herpes Genitalis | 2 | 2022 | 6 | 0.360 |
Why?
|
Sexual and Gender Minorities | 2 | 2021 | 22 | 0.350 |
Why?
|
Male | 27 | 2022 | 14117 | 0.350 |
Why?
|
Genomics | 5 | 2021 | 53 | 0.350 |
Why?
|
Animals | 14 | 2023 | 3396 | 0.340 |
Why?
|
Saliva | 2 | 2022 | 43 | 0.340 |
Why?
|
Eating | 2 | 2021 | 47 | 0.340 |
Why?
|
Humans | 35 | 2024 | 26246 | 0.340 |
Why?
|
Female | 25 | 2024 | 14509 | 0.330 |
Why?
|
Intestines | 3 | 2021 | 94 | 0.330 |
Why?
|
Food Hypersensitivity | 2 | 2021 | 39 | 0.320 |
Why?
|
Starch | 2 | 2019 | 9 | 0.300 |
Why?
|
RNA, Ribosomal, 16S | 7 | 2024 | 51 | 0.300 |
Why?
|
Disease Models, Animal | 5 | 2023 | 568 | 0.290 |
Why?
|
Mice, Inbred C57BL | 8 | 2023 | 370 | 0.290 |
Why?
|
Dietary Fiber | 2 | 2017 | 20 | 0.290 |
Why?
|
HIV Infections | 2 | 2022 | 463 | 0.280 |
Why?
|
Vagina | 2 | 2024 | 30 | 0.280 |
Why?
|
Alcohol Drinking | 2 | 2019 | 69 | 0.280 |
Why?
|
Cross Infection | 2 | 2021 | 276 | 0.270 |
Why?
|
Colon, Sigmoid | 2 | 2017 | 17 | 0.260 |
Why?
|
Sinusitis | 2 | 2018 | 159 | 0.260 |
Why?
|
Milk, Human | 2 | 2019 | 179 | 0.250 |
Why?
|
Herpesvirus 2, Human | 3 | 2022 | 8 | 0.250 |
Why?
|
Ulcer | 2 | 2017 | 7 | 0.250 |
Why?
|
Colitis | 2 | 2023 | 36 | 0.250 |
Why?
|
Mice | 8 | 2023 | 1282 | 0.240 |
Why?
|
Toilet Facilities | 1 | 2024 | 2 | 0.240 |
Why?
|
Rain | 1 | 2024 | 3 | 0.240 |
Why?
|
Bacteria | 3 | 2024 | 74 | 0.240 |
Why?
|
Immune System | 2 | 2021 | 14 | 0.240 |
Why?
|
Enterobacteriaceae | 2 | 2024 | 33 | 0.230 |
Why?
|
Circumcision, Male | 2 | 2022 | 7 | 0.230 |
Why?
|
Laboratories, Hospital | 1 | 2024 | 5 | 0.230 |
Why?
|
Sexually Transmitted Diseases | 1 | 2023 | 14 | 0.220 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 12 | 0.210 |
Why?
|
Community-Acquired Infections | 2 | 2021 | 68 | 0.210 |
Why?
|
Kenya | 5 | 2023 | 11 | 0.210 |
Why?
|
Circumcision, Female | 1 | 2022 | 2 | 0.210 |
Why?
|
Butyrates | 2 | 2019 | 22 | 0.200 |
Why?
|
Shift Work Schedule | 1 | 2022 | 6 | 0.200 |
Why?
|
Biodiversity | 2 | 2019 | 35 | 0.200 |
Why?
|
Mouth | 1 | 2022 | 12 | 0.200 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 17 | 0.200 |
Why?
|
Dietary Supplements | 1 | 2021 | 55 | 0.190 |
Why?
|
Toll-Like Receptor 4 | 2 | 2018 | 33 | 0.190 |
Why?
|
Universities | 1 | 2021 | 35 | 0.190 |
Why?
|
Milk | 1 | 2021 | 14 | 0.190 |
Why?
|
Disease Outbreaks | 1 | 2021 | 78 | 0.190 |
Why?
|
Adult | 11 | 2022 | 7441 | 0.190 |
Why?
|
Students | 1 | 2021 | 39 | 0.190 |
Why?
|
Schistosomiasis | 1 | 2021 | 7 | 0.190 |
Why?
|
Animal Husbandry | 1 | 2020 | 8 | 0.180 |
Why?
|
Ethanol | 3 | 2019 | 113 | 0.180 |
Why?
|
Young Adult | 6 | 2024 | 1888 | 0.180 |
Why?
|
Macaca mulatta | 1 | 2020 | 56 | 0.180 |
Why?
|
Weight Gain | 1 | 2020 | 61 | 0.180 |
Why?
|
Fresh Water | 1 | 2020 | 4 | 0.180 |
Why?
|
Phenotype | 1 | 2021 | 290 | 0.180 |
Why?
|
Fatty Acids, Volatile | 4 | 2023 | 34 | 0.170 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2020 | 43 | 0.170 |
Why?
|
Enterobacteriaceae Infections | 1 | 2020 | 39 | 0.170 |
Why?
|
Colonic Polyps | 1 | 2019 | 21 | 0.170 |
Why?
|
Trisaccharides | 1 | 2019 | 3 | 0.160 |
Why?
|
Influenza Vaccines | 1 | 2019 | 9 | 0.160 |
Why?
|
Astronauts | 1 | 2019 | 4 | 0.160 |
Why?
|
Space Flight | 1 | 2019 | 6 | 0.160 |
Why?
|
Microglia | 1 | 2020 | 135 | 0.160 |
Why?
|
Specimen Handling | 1 | 2019 | 40 | 0.160 |
Why?
|
Mucous Membrane | 1 | 2019 | 29 | 0.160 |
Why?
|
Osteolysis | 1 | 2020 | 138 | 0.160 |
Why?
|
Adaptation, Physiological | 1 | 2019 | 43 | 0.160 |
Why?
|
Firmicutes | 1 | 2019 | 6 | 0.160 |
Why?
|
Feeding Behavior | 1 | 2019 | 75 | 0.160 |
Why?
|
Rotenone | 1 | 2018 | 9 | 0.160 |
Why?
|
Influenza, Human | 1 | 2019 | 40 | 0.160 |
Why?
|
Prostheses and Implants | 1 | 2020 | 159 | 0.160 |
Why?
|
Photoperiod | 2 | 2019 | 39 | 0.160 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 35 | 0.160 |
Why?
|
Tea | 1 | 2018 | 3 | 0.150 |
Why?
|
Mouth Mucosa | 1 | 2018 | 10 | 0.150 |
Why?
|
Mouth Neoplasms | 1 | 2018 | 19 | 0.150 |
Why?
|
Adolescent | 5 | 2024 | 2080 | 0.150 |
Why?
|
Intestinal Mucosa | 2 | 2019 | 184 | 0.150 |
Why?
|
Rhinitis, Allergic | 1 | 2018 | 16 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 22 | 0.150 |
Why?
|
Prosthesis-Related Infections | 1 | 2020 | 185 | 0.150 |
Why?
|
Obesity | 1 | 2020 | 278 | 0.150 |
Why?
|
MicroRNAs | 1 | 2018 | 42 | 0.150 |
Why?
|
Antioxidants | 1 | 2018 | 55 | 0.150 |
Why?
|
Nose | 1 | 2018 | 36 | 0.150 |
Why?
|
Defecation | 1 | 2017 | 4 | 0.140 |
Why?
|
Dermatitis, Atopic | 1 | 2017 | 11 | 0.140 |
Why?
|
Microspheres | 1 | 2017 | 22 | 0.140 |
Why?
|
Pilot Projects | 4 | 2020 | 378 | 0.140 |
Why?
|
Parkinsonian Disorders | 1 | 2020 | 218 | 0.140 |
Why?
|
Asthma | 1 | 2018 | 109 | 0.140 |
Why?
|
Chicago | 4 | 2021 | 846 | 0.140 |
Why?
|
Multiple System Atrophy | 1 | 2017 | 35 | 0.130 |
Why?
|
Bacteremia | 1 | 2017 | 97 | 0.130 |
Why?
|
Rhinitis | 1 | 2018 | 142 | 0.130 |
Why?
|
Circadian Clocks | 1 | 2016 | 30 | 0.130 |
Why?
|
Brain | 2 | 2021 | 1642 | 0.120 |
Why?
|
Anti-Infective Agents, Local | 1 | 2015 | 45 | 0.120 |
Why?
|
Alcoholism | 1 | 2015 | 64 | 0.120 |
Why?
|
alpha-Synuclein | 1 | 2015 | 121 | 0.110 |
Why?
|
Prospective Studies | 3 | 2024 | 1673 | 0.110 |
Why?
|
Bacteria, Anaerobic | 1 | 2012 | 1 | 0.100 |
Why?
|
Genital Diseases, Male | 1 | 2012 | 7 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2012 | 49 | 0.100 |
Why?
|
Time Factors | 3 | 2020 | 1382 | 0.100 |
Why?
|
Sexual Partners | 2 | 2022 | 16 | 0.100 |
Why?
|
Homosexuality, Male | 2 | 2021 | 21 | 0.090 |
Why?
|
Microbial Sensitivity Tests | 2 | 2021 | 73 | 0.090 |
Why?
|
Illinois | 2 | 2021 | 230 | 0.090 |
Why?
|
Prevalence | 2 | 2021 | 435 | 0.080 |
Why?
|
Carcinogenesis | 2 | 2019 | 22 | 0.080 |
Why?
|
Molecular Epidemiology | 2 | 2021 | 25 | 0.080 |
Why?
|
Phylogeny | 2 | 2021 | 46 | 0.080 |
Why?
|
Middle Aged | 5 | 2018 | 8589 | 0.070 |
Why?
|
Genome, Bacterial | 2 | 2017 | 13 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 51 | 0.070 |
Why?
|
Chronic Disease | 2 | 2018 | 419 | 0.070 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 104 | 0.060 |
Why?
|
Sanitation | 1 | 2024 | 2 | 0.060 |
Why?
|
Hygiene | 1 | 2024 | 12 | 0.060 |
Why?
|
Child | 2 | 2020 | 1234 | 0.060 |
Why?
|
Public Health Surveillance | 1 | 2024 | 11 | 0.060 |
Why?
|
Menstrual Hygiene Products | 1 | 2023 | 4 | 0.060 |
Why?
|
Public Health | 1 | 2024 | 63 | 0.050 |
Why?
|
Dextran Sulfate | 1 | 2023 | 11 | 0.050 |
Why?
|
Schools | 1 | 2023 | 44 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 313 | 0.050 |
Why?
|
Proof of Concept Study | 1 | 2022 | 8 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 97 | 0.050 |
Why?
|
Travel-Related Illness | 1 | 2021 | 3 | 0.050 |
Why?
|
Methicillin | 1 | 2021 | 6 | 0.050 |
Why?
|
Molecular Typing | 1 | 2021 | 8 | 0.050 |
Why?
|
Pasteurization | 1 | 2021 | 3 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 63 | 0.050 |
Why?
|
Leptin | 1 | 2020 | 19 | 0.050 |
Why?
|
Cadherins | 1 | 2020 | 34 | 0.050 |
Why?
|
Fusobacteria | 1 | 2020 | 2 | 0.050 |
Why?
|
Anilides | 1 | 2020 | 6 | 0.040 |
Why?
|
Pregnancy | 1 | 2021 | 311 | 0.040 |
Why?
|
Food | 1 | 2020 | 29 | 0.040 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2020 | 18 | 0.040 |
Why?
|
Glucose | 1 | 2020 | 48 | 0.040 |
Why?
|
Neurotoxins | 1 | 2020 | 14 | 0.040 |
Why?
|
Random Allocation | 1 | 2020 | 119 | 0.040 |
Why?
|
Lactobacillus | 1 | 2020 | 19 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2020 | 42 | 0.040 |
Why?
|
Pyridines | 1 | 2020 | 36 | 0.040 |
Why?
|
Waste Disposal, Fluid | 1 | 2020 | 3 | 0.040 |
Why?
|
Water Microbiology | 1 | 2020 | 9 | 0.040 |
Why?
|
Escherichia coli Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
Insulin | 1 | 2020 | 76 | 0.040 |
Why?
|
Health Personnel | 1 | 2021 | 98 | 0.040 |
Why?
|
Blood Glucose | 1 | 2020 | 99 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 84 | 0.040 |
Why?
|
Infection Control | 1 | 2021 | 163 | 0.040 |
Why?
|
Immunity, Mucosal | 1 | 2019 | 18 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 23 | 0.040 |
Why?
|
Period Circadian Proteins | 1 | 2019 | 21 | 0.040 |
Why?
|
beta-Lactamases | 1 | 2020 | 72 | 0.040 |
Why?
|
Freezing | 1 | 2019 | 12 | 0.040 |
Why?
|
Penis | 1 | 2020 | 81 | 0.040 |
Why?
|
Galactose | 1 | 2019 | 3 | 0.040 |
Why?
|
Fructose | 1 | 2019 | 5 | 0.040 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2019 | 2 | 0.040 |
Why?
|
Telomere Homeostasis | 1 | 2019 | 2 | 0.040 |
Why?
|
Cecum | 1 | 2019 | 11 | 0.040 |
Why?
|
Genomic Instability | 1 | 2019 | 8 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 186 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2019 | 13 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2019 | 76 | 0.040 |
Why?
|
Carotid Intima-Media Thickness | 1 | 2019 | 15 | 0.040 |
Why?
|
Adaptive Immunity | 1 | 2019 | 15 | 0.040 |
Why?
|
DNA Damage | 1 | 2019 | 24 | 0.040 |
Why?
|
Th1 Cells | 1 | 2019 | 26 | 0.040 |
Why?
|
Vaccination | 1 | 2019 | 29 | 0.040 |
Why?
|
Solanum tuberosum | 1 | 2019 | 3 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2019 | 200 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2019 | 47 | 0.040 |
Why?
|
CD3 Complex | 1 | 2018 | 5 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2019 | 32 | 0.040 |
Why?
|
Fatty Acids | 1 | 2019 | 36 | 0.040 |
Why?
|
Rats | 1 | 2020 | 598 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2019 | 87 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2021 | 281 | 0.040 |
Why?
|
Body Weight | 1 | 2019 | 121 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 338 | 0.040 |
Why?
|
Gingiva | 1 | 2018 | 2 | 0.040 |
Why?
|
Streptococcus | 1 | 2018 | 2 | 0.040 |
Why?
|
Catechin | 1 | 2018 | 3 | 0.040 |
Why?
|
Staphylococcus | 1 | 2018 | 9 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2018 | 66 | 0.040 |
Why?
|
Epithelium | 1 | 2018 | 23 | 0.040 |
Why?
|
Protective Agents | 1 | 2018 | 9 | 0.040 |
Why?
|
Smokers | 1 | 2018 | 11 | 0.040 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 19 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 26 | 0.040 |
Why?
|
DNA Methylation | 1 | 2019 | 122 | 0.040 |
Why?
|
Pancreas | 1 | 2018 | 28 | 0.040 |
Why?
|
Genitalia | 1 | 2017 | 3 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2018 | 264 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 855 | 0.040 |
Why?
|
Disease Progression | 1 | 2020 | 687 | 0.040 |
Why?
|
Biomarkers | 1 | 2020 | 556 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 95 | 0.040 |
Why?
|
South Africa | 1 | 2017 | 11 | 0.040 |
Why?
|
Fermentation | 1 | 2017 | 11 | 0.040 |
Why?
|
Constipation | 1 | 2017 | 18 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2017 | 39 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 564 | 0.040 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2017 | 16 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 52 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2017 | 399 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 25 | 0.030 |
Why?
|
CLOCK Proteins | 1 | 2016 | 22 | 0.030 |
Why?
|
Diet | 1 | 2017 | 170 | 0.030 |
Why?
|
Protein Folding | 1 | 2015 | 18 | 0.030 |
Why?
|
Infant | 1 | 2017 | 520 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 592 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 1146 | 0.030 |
Why?
|
Bacterial Translocation | 1 | 2015 | 22 | 0.030 |
Why?
|
Endotoxemia | 1 | 2015 | 24 | 0.030 |
Why?
|
Probiotics | 1 | 2015 | 18 | 0.030 |
Why?
|
Permeability | 1 | 2015 | 116 | 0.030 |
Why?
|
Dietary Sucrose | 1 | 2014 | 7 | 0.030 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2015 | 39 | 0.030 |
Why?
|
Diet, High-Fat | 1 | 2014 | 10 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 2271 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 1842 | 0.030 |
Why?
|
Light | 1 | 2014 | 60 | 0.030 |
Why?
|
United States | 1 | 2019 | 1991 | 0.030 |
Why?
|
RNA, Bacterial | 1 | 2012 | 3 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2012 | 43 | 0.030 |
Why?
|
Cognition | 1 | 2020 | 1290 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 3365 | 0.020 |
Why?
|
Aged | 1 | 2015 | 8754 | 0.010 |
Why?
|